Trinity Biotech Plc (TRIB)
0.78
+0.01
(+1.95%)
USD |
NASDAQ |
Mar 16, 11:56
Trinity Biotech EPS Diluted (Quarterly) : -0.274 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amarin Corp. Plc | -0.0587 |
| DBV Technologies SA | -1.207 |
| Ascendis Pharma A/S | -0.6364 |
| Cellectis SA | 0.0058 |
| Akari Therapeutics Plc | -0.1947 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.112M |
| Revenue (Quarterly) | 14.25M |
| Total Expenses (Quarterly) | 19.36M |
| Enterprise Value | 130.12M |
| Gross Profit Margin (Quarterly) | 42.72% |
| Profit Margin (Quarterly) | -35.88% |
| Earnings Yield | -301.2% |
| Normalized Earnings Yield | -269.37 |